1,4-Benzenedicarboxaldehyde, 2,5-dichloro-, 98%, 1g

4-Chloro-2-fluoro-3-methylbenzaldehyde, 98+%, 1g

DL-3-Aminoisobutyric Acid>98.0%(T)1g

(4-(1-(TERT-BUTOXYCARBONYL)-1,2,3,6-TETRAHYDROPYRIDIN-4-YL)PHENYL)BORONIC ACID PINACOL ESTER, 90.0%, 5g

tert-Butyl (2-chlorothiazol-5-yl)carbamate, 97%, 25g

4-(Difluoromethoxy)iodobenzene, 98.0%, 25g

GC capillary column ROTI®Cap-5 MS, 60 m, 0.32 mm, 1.00 µm, 1 Piece(s)

N-(1-Oxo-2,3-dihydro-1H-inden-5-yl)acetamide, 95.0%, 25g

Methyl 6-nitro-1H-indazole-4-carboxylate, 95.0%, 5g

7-methyl-5-phenyl-1,3,4,5-tetrahydro-2H-benzo[e][1,4]diazepin-2-one, 95.0%, 250mg

4-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)PHENOL, 95.0%, 1g

1-(4-BROMOBUTYL)-4-CHLORO-1H-PYRAZOLE, 95.0%, 1g

1-Methyl-4-vinylbenzene (stabilised with TBC), 96.0%, 5g